177Lu-FAPI-46

¹⁷⁷Lu-FAPI-46 refers to an investigational radiopharmaceutical designed for targeted radionuclide therapy in cancer.This therapy approach aims to deliver localized radiation to cancer cells by specifically targeting FAP-expressing cells in the tumor microenvironment. The use of Lutetium-177 as the radionuclide in this context suggests that it emits beta particles, which can be effective in damaging nearby cancer cells while sparing healthy tissue.

Virtual price, please inquire if needed.We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time.

msds of 177Lu-FAPI-46